News on molecular diagnostics, pharmacogenomics tests for coronary artery disease, congenital heart defects, and more.
The project will focus on metabolic biomarkers that previous research has linked to heart disease, type 2 diabetes, and other common chronic diseases.
The effort will provide individuals with genetic testing to determine if they have the disorder, and when necessary, with genetic testing counselling.
In a family with unusually low LDL cholesterol levels, researchers in China found a variant in the LIMA1 gene through exome sequencing.
Rainbow will offer Color's hereditary cancer and heart health genetic risk assessment tests to patients in Hong Kong.
Three microRNA that were significantly upregulated in plaques may serve as targets to affect cardiovascular disease development, according to a new study.
